Skip to search.
 FTSE 100 Down 1.37%

Arena Pharmaceuticals, Inc. (ARNA)

-NasdaqGS
4.34 Down 0.02(0.46%) 26 Mar 20:00
|After Hours: : 4.34 0.00 (0.00%) 20:37
Add to Portfolio
Prev Close:4.36
Open:4.30
Bid:4.23 x 500
Ask:4.46 x 3000
1y Target Est:7.58
Beta:-4.12
Earnings Date:11 May - 15 May (Est.)
Day's Range:4.21 - 4.47
52wk Range:3.26 - 7.22
Volume:3,406,558
Avg Vol (3m):9,092,740
Market Cap:1.05b
P/E (ttm):N/A
EPS (ttm):-0.28
Div & Yield:N/A (N/A)
Trade Now
Quotes delayed, except where indicated otherwise. Currency in USD.

Comparison

Symbol% ChgMkt Cap
ARNADown 0.46%1.05b
GSKDown 1.46%112.24b
OREXUp 4.77%897.02m
RHHBYDown 1.61%N/A

Key Statistics

Forward P/E (1 yr):N/A
P/S (ttm):28.48
Ex-Dividend Date:N/A

Analysts

Annual EPS Est (Dec-15) :-0.53
Quarterly EPS Est (Mar-15) :-0.14
Mean Recommendation*:2.7
PEG Ratio (5 yr expected):0.47

* (Strong Buy) 1.0 - 5.0 (Sell)

Analyst Opinion | Estimates

Business Summary

Arena Pharmaceuticals, Inc., a biopharmaceutical company, discovers, develops, and commercializes novel drugs that target G protein-coupled receptors. The company offers BELVIQ, a drug used to treat chronic weight management in adults. more
Your browser doesn't support canvas
SETTINGS
Scrolling
Speed
Display
Price
Submit Feedback